NCT02818491View on ClinicalTrials.gov

Dexamethasone as an Adjuvant to Ropivacaine for the Interscalene Brachial Plexus Block

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

November 1, 2018

Study Completion Date

November 1, 2018

Conditions
Postoperative Pain
Interventions
DRUG

Placebo

Normal saline 0.9% in 2 mls

DRUG

Dexamethasone 1 mg

Dexamethasone 1 mg in 2 mls

DRUG

Dexamethasone 2 mg

Dexamethasone 2 mg in 2 mls

DRUG

Dexamethasone 3 mg

Dexamethasone 3 mg in 2 mls

DRUG

Dexamethasone 4 mg

Dexamethasone 4 mg in 2 mls

DRUG

Ropivacaine 0.5%

Ropivacaine 0.5% 20 mls

Trial Locations (1)

8500

AZ Groeninge Hospital, Kortrijk

All Listed Sponsors
lead

Centre Hospitalier Universitaire Vaudois

OTHER

NCT02818491 - Dexamethasone as an Adjuvant to Ropivacaine for the Interscalene Brachial Plexus Block | Biotech Hunter | Biotech Hunter